Evidence map›Paper›PMID 37023193›Full record

ArticleScience (New York, N.Y.)2023

Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses.

Ellen L Shrock, Richard T Timms, Tomasz Kula, Elijah L Mena, Anthony P West, Rui Guo, I-Hsiu Lee, Alexander A Cohen, Lindsay G A McKay, Caihong Bi and 9 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
20.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Explore antibody repertoire in the era of AI.Acta biochimica et biophysica Sinica · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Ellen L ShrockDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2484-4374
Richard T Timms *Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7275-597X
Tomasz Kula *Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-6458-9833
Elijah L MenaDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-9980-9018
Anthony P WestDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0003-4213-5184
Rui GuoDivision of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-4584-1324
I-Hsiu LeeCenter for Systems Biology, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0001-7200-7867
Alexander A CohenDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-2818-656X
Lindsay G A McKayNational Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.ORCID 0000-0003-0369-9067
Caihong BiDivision of Allergy and Immunology, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Yumei LengDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2512-9284
Eric FujimuraDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-8213-2143
Felix HornsDepartment of Bioengineering, Department of Applied Physics, Chan Zuckerberg Biohub and Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-5872-5061
Mamie LiDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-7188-1330
Duane R WesemannBroad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.ORCID 0000-0002-6690-944X
Anthony GriffithsNational Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.ORCID 0000-0001-5435-8364
Benjamin E GewurzDivision of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Pamela J BjorkmanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-2277-3990
Stephen J ElledgeDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-7923-6283
Brigham and Women's Hospital · USBroad Institute · USCalifornia Institute of Technology · USBoston University · USCenter for Systems Biology · USChan Zuckerberg Initiative (United States) · USUniversity of Cambridge · GB

Funding

Technology and Computational CoreP01AI165072 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WESEMANN, DUANE R. · 2021 to 2023
$19.6M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Flipped Germinal CentersR01AI169619 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WESEMANN, DUANE R. · 2021 to 2025
$3.7M
Antibody Durability DynamicsR01AI170715 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Duane R. Wesemann · 2022 to 2026
$3.4M
Elucidating Germinal Center-Mediated Antibody EvolutionR01AI139538 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WESEMANN, DUANE R. · 2019 to 2022
$2.4M
Targeting the HIV reservoir using optimized anti-HIV antibodiesR01AI129784 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BJORKMAN, PAMELA J · 2017 to 2021
$2.1M
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cellsR00DE031016 · NIDCR · TUFTS UNIVERSITY BOSTON · PI GUO, RUI · 2023 to 2025
$747k
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cellsK99DE031016 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI GUO, RUI · 2022 to 2023
$232k
Howard Hughes Medical InstituteNIAID NIH HHS P01 AI165072NIAID NIH HHS R01 AI129784NIAID NIH HHS R01 AI139538NIAID NIH HHS R01 AI169619NIAID NIH HHS R01 AI170715NIDCR NIH HHS K99 DE031016NIDCR NIH HHS R00 DE031016NIGMS NIH HHS P41 GM103311Wellcome Trust
6 · The paper itself

Abstract

Despite the vast diversity of the antibody repertoire, infected individuals often mount antibody responses to precisely the same epitopes within antigens. The immunological mechanisms underpinning this phenomenon remain unknown. By mapping 376 immunodominant "public epitopes" at high resolution and characterizing several of their cognate antibodies, we concluded that germline-encoded sequences in antibodies drive recurrent recognition. Systematic analysis of antibody-antigen structures uncovered 18 human and 21 partially overlapping mouse germline-encoded amino acid-binding (GRAB) motifs within heavy and light V gene segments that in case studies proved critical for public epitope recognition. GRAB motifs represent a fundamental component of the immune system's architecture that promotes recognition of pathogens and leads to species-specific public antibody responses that can exert selective pressure on pathogens.

Indexed as

Amino Acid MotifsAntibody FormationHost-Pathogen InteractionsImmunodominant EpitopesImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsAnimalsEpitope MappingGerm CellsHumansMiceImmunodominant EpitopesImmunoglobulin Heavy ChainsImmunoglobulin Light Chains

Identifiers

PMID37023193
PMCPMC10273302
OpenAlexW4362659805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.